Systematic analysis of transcriptome signature for improving outcomes in lung adenocarcinoma
- 9 May 2023
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (11) , 8951-8968
Abstract
Purpose The updated guidelines highlight gene expression-based multigene panel as a critical tool to assess overall survival (OS) and improve treatment for lung adenocarcinoma (LUAD) patients. Nevertheless, genome-wide expression signatures are still limited in real clinical utility because of insufficient data utilization, a lack of critical validation, and inapposite machine learning algorithms. Methods 2330 primary LUAD samples were enrolled from 11 independent cohorts. Seventy-six algorithm combinations based on ten machine learning algorithms were applied. A total of 108 published gene expression signatures were collected. Multiple pharmacogenomics databases and resources were utilized to identify precision therapeutic drugs. Results We comprehensively developed a robust machine learning-derived genome-wide expression signature (RGS) according to stably OS-associated RNAs (OSRs). RGS was an independent risk element and remained robust and reproducible power by comparing it with general clinical parameters, molecular characteristics, and 108 published signatures. RGS-based stratification possessed different biological behaviors, molecular mechanisms, and immune microenvironment patterns. Integrating multiple databases and previous studies, we identified that alisertib was sensitive to the high-risk group, and RITA was sensitive to the low-risk group. Conclusion Our study offers an appealing platform to screen dismal prognosis LUAD patients to improve clinical outcomes by optimizing precision therapy.Keywords
This publication has 50 references indexed in Scilit:
- Development of a Likelihood of Survival Scoring System for Hospitalized Equine Neonates Using Generalized Boosted Regression ModelingPLOS ONE, 2014
- Deviance residuals-based sparse PLS and sparse kernel PLS regression for censored dataBioinformatics, 2014
- Frequency of EGFR Mutations in 907 Lung Adenocarcioma Patients of Indian EthnicityPLOS ONE, 2013
- EGFR Mutations in Indian Lung Cancer Patients: Clinical Correlation and Outcome to EGFR Targeted TherapyPLOS ONE, 2013
- Random Survival ForestsJournal of Thoracic Oncology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Improved performance on high-dimensional survival data by application of Survival-SVMBioinformatics, 2010
- The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and DiseaseScience, 2006
- RITA - a small-molecule anticancer drug that targets p53Expert Opinion on Investigational Drugs, 2005
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004